GlassScriptPhysician profile
Mark S Wyatt
NPI 1245347194
$17,169.46
in general payments reported to CMS, 2019-2025
20 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $15.71 · 2021: $122 · 2022: $15K · 2023: $405 · 2024: $1,715 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463 · Travel and Lodging: $753 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.12 |
| Travel and Lodging | $752.84 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,017.29 | 2022-2025 | Da Vinci Surgical System |
| Kerecis Limited | $259.62 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Davol INC. | $209.21 | 2019-2023 | Phasix Mesh |
| Conmed Corporation | $148.11 | 2024-2025 | Airseal |
| Heron Therapeutics, INC. | $70.33 | 2021-2023 | Zynrelef |
| Becton, Dickinson and Company | $67.34 | 2024 | Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $66.22 | 2022-2024 | |
| Integra Lifesciences Corporation | $47.95 | 2021-2022 | |
| Baxter Healthcare | $41.30 | 2021 | |
| Innocoll Pharmaceuticals Limited | $40.46 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $32.37 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $29.89 | 2019 | |
| Ethicon US, LLC | $21.68 | 2023 | Ethicon, Echelon Flex, Stratafix |
| Acera Surgical, INC. | $19.58 | 2019 | |
| Solventum Corporation | $18.02 | 2025 | Abthera Advance, Prevena, V.A.C. Veraflo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.62 | 2019 | |
| Shire North American Group INC | $16.77 | 2019 | |
| Kci USA, INC. | $16.42 | 2022 | |
| Teleflex LLC | $15.71 | 2020 | |
| Tela Bio, INC. | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wyatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.